Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Expression of AXL receptor tyrosine kinase relates to monocyte dysfunction and severity of cirrhosis.

Brenig R, Pop OT, Triantafyllou E, Geng A, Singanayagam A, Perez-Shibayama C, Besse L, Cupovic J, Künzler P, Boldanova T, Brand S, Semela D, Duong FH, Weston CJ, Ludewig B, Heim MH, Wendon J, Antoniades CG, Bernsmeier C.

Life Sci Alliance. 2019 Dec 10;3(1). pii: e201900465. doi: 10.26508/lsa.201900465. Print 2020 Jan.

2.

Danger of Herbal Tea: A Case of Acute Cholestatic Hepatitis Due to Artemisia annua Tea.

Ruperti-Repilado FJ, Haefliger S, Rehm S, Zweier M, Rentsch KM, Blum J, Jetter A, Heim M, Leuppi-Taegtmeyer A, Terracciano L, Bernsmeier C.

Front Med (Lausanne). 2019 Oct 11;6:221. doi: 10.3389/fmed.2019.00221. eCollection 2019.

3.

[Wilson's disease or hepatolenticular degeneration].

Mensing B, Nowak A, Zweifel S, Terracciano L, Bernsmeier C, Filipowicz Sinnreich M.

Ther Umsch. 2018 Nov;75(4):241-248. doi: 10.1024/0040-5930/a000995. German.

PMID:
30468117
4.

CD14+ CD15- HLA-DR- myeloid-derived suppressor cells impair antimicrobial responses in patients with acute-on-chronic liver failure.

Bernsmeier C, Triantafyllou E, Brenig R, Lebosse FJ, Singanayagam A, Patel VC, Pop OT, Khamri W, Nathwani R, Tidswell R, Weston CJ, Adams DH, Thursz MR, Wendon JA, Antoniades CG.

Gut. 2018 Jun;67(6):1155-1167. doi: 10.1136/gutjnl-2017-314184. Epub 2017 Jun 7.

5.

MerTK expressing hepatic macrophages promote the resolution of inflammation in acute liver failure.

Triantafyllou E, Pop OT, Possamai LA, Wilhelm A, Liaskou E, Singanayagam A, Bernsmeier C, Khamri W, Petts G, Dargue R, Davies SP, Tickle J, Yuksel M, Patel VC, Abeles RD, Stamataki Z, Curbishley SM, Ma Y, Wilson ID, Coen M, Woollard KJ, Quaglia A, Wendon J, Thursz MR, Adams DH, Weston CJ, Antoniades CG.

Gut. 2018 Feb;67(2):333-347. doi: 10.1136/gutjnl-2016-313615. Epub 2017 Apr 27.

6.

Increased Expression of Cytotoxic T-Lymphocyte-Associated Protein 4 by T Cells, Induced by B7 in Sera, Reduces Adaptive Immunity in Patients With Acute Liver Failure.

Khamri W, Abeles RD, Hou TZ, Anderson AE, El-Masry A, Triantafyllou E, Bernsmeier C, Larsen FS, Singanayagam A, Kudo N, Possamai LA, Lebosse F, Auzinger G, Bernal W, Willars C, Weston CJ, Lombardi G, Wendon J, Thursz M, Antoniades CG.

Gastroenterology. 2017 Jul;153(1):263-276.e8. doi: 10.1053/j.gastro.2017.03.023. Epub 2017 Mar 28.

7.

Liver dendritic cells and NAFLD evolution: A remaining open issue.

Bernsmeier C, Albano E.

J Hepatol. 2017 Jun;66(6):1120-1122. doi: 10.1016/j.jhep.2017.02.018. Epub 2017 Feb 23. No abstract available.

PMID:
28237398
8.

Hepatic Notch1 deletion predisposes to diabetes and steatosis via glucose-6-phosphatase and perilipin-5 upregulation.

Bernsmeier C, Dill MT, Provenzano A, Makowska Z, Krol I, Muscogiuri G, Semela D, Tornillo L, Marra F, Heim MH, Duong FH.

Lab Invest. 2016 Sep;96(9):972-80. doi: 10.1038/labinvest.2016.75. Epub 2016 Jul 18.

9.

Defective monocyte oxidative burst predicts infection in alcoholic hepatitis and is associated with reduced expression of NADPH oxidase.

Vergis N, Khamri W, Beale K, Sadiq F, Aletrari MO, Moore C, Atkinson SR, Bernsmeier C, Possamai LA, Petts G, Ryan JM, Abeles RD, James S, Foxton M, Hogan B, Foster GR, O'Brien AJ, Ma Y, Shawcross DL, Wendon JA, Antoniades CG, Thursz MR.

Gut. 2017 Mar;66(3):519-529. doi: 10.1136/gutjnl-2015-310378. Epub 2016 Feb 9.

10.

Sleep Disruption and Daytime Sleepiness Correlating with Disease Severity and Insulin Resistance in Non-Alcoholic Fatty Liver Disease: A Comparison with Healthy Controls.

Bernsmeier C, Weisskopf DM, Pflueger MO, Mosimann J, Campana B, Terracciano L, Beglinger C, Heim MH, Cajochen C.

PLoS One. 2015 Nov 17;10(11):e0143293. doi: 10.1371/journal.pone.0143293. eCollection 2015.

11.

Neutrophil Toll-Like Receptor 9 Expression and the Systemic Inflammatory Response in Acetaminophen-Induced Acute Liver Failure.

Manakkat Vijay GK, Ryan JM, Abeles RD, Ramage S, Patel V, Bernsmeier C, Riva A, McPhail MJ, Tranah TH, Markwick LJ, Taylor NJ, Bernal W, Auzinger G, Willars C, Chokshi S, Wendon JA, Ma Y, Shawcross DL.

Crit Care Med. 2016 Jan;44(1):43-53. doi: 10.1097/CCM.0000000000001309.

PMID:
26457748
12.

High-volume plasma exchange in patients with acute liver failure: An open randomised controlled trial.

Larsen FS, Schmidt LE, Bernsmeier C, Rasmussen A, Isoniemi H, Patel VC, Triantafyllou E, Bernal W, Auzinger G, Shawcross D, Eefsen M, Bjerring PN, Clemmesen JO, Hockerstedt K, Frederiksen HJ, Hansen BA, Antoniades CG, Wendon J.

J Hepatol. 2016 Jan;64(1):69-78. doi: 10.1016/j.jhep.2015.08.018. Epub 2015 Aug 29.

PMID:
26325537
13.

Immunotherapy in the treatment and prevention of infection in acute-on-chronic liver failure.

Bernsmeier C, Singanayagam A, Patel VC, Wendon J, Antoniades CG.

Immunotherapy. 2015;7(6):641-54. doi: 10.2217/imt.15.27. Epub 2015 Jun 12. Review.

PMID:
26065379
14.

Patients with acute-on-chronic liver failure have increased numbers of regulatory immune cells expressing the receptor tyrosine kinase MERTK.

Bernsmeier C, Pop OT, Singanayagam A, Triantafyllou E, Patel VC, Weston CJ, Curbishley S, Sadiq F, Vergis N, Khamri W, Bernal W, Auzinger G, Heneghan M, Ma Y, Jassem W, Heaton ND, Adams DH, Quaglia A, Thursz MR, Wendon J, Antoniades CG.

Gastroenterology. 2015 Mar;148(3):603-615.e14. doi: 10.1053/j.gastro.2014.11.045. Epub 2014 Dec 3.

PMID:
25479139
15.

What's new in acute liver failure?

Bernsmeier C, Antoniades CG, Wendon J.

Intensive Care Med. 2014 Oct;40(10):1545-8. doi: 10.1007/s00134-014-3350-4. Epub 2014 Jul 1. No abstract available.

PMID:
24981954
16.

The liver may act as a firewall mediating mutualism between the host and its gut commensal microbiota.

Balmer ML, Slack E, de Gottardi A, Lawson MA, Hapfelmeier S, Miele L, Grieco A, Van Vlierberghe H, Fahrner R, Patuto N, Bernsmeier C, Ronchi F, Wyss M, Stroka D, Dickgreber N, Heim MH, McCoy KD, Macpherson AJ.

Sci Transl Med. 2014 May 21;6(237):237ra66. doi: 10.1126/scitranslmed.3008618.

17.

Glucose-induced glucagon-like Peptide 1 secretion is deficient in patients with non-alcoholic fatty liver disease.

Bernsmeier C, Meyer-Gerspach AC, Blaser LS, Jeker L, Steinert RE, Heim MH, Beglinger C.

PLoS One. 2014 Jan 29;9(1):e87488. doi: 10.1371/journal.pone.0087488. eCollection 2014.

18.

Hepatitis C virus dysregulates glucose homeostasis by a dual mechanism involving induction of PGC1α and dephosphorylation of FoxO1.

Bernsmeier C, Calabrese D, Heim MH, Duong HT.

J Viral Hepat. 2014 Jan;21(1):9-18. doi: 10.1111/jvh.12208. Epub 2013 Nov 6.

PMID:
24329853
19.

Secretory leukocyte protease inhibitor: a pivotal mediator of anti-inflammatory responses in acetaminophen-induced acute liver failure.

Antoniades CG, Khamri W, Abeles RD, Taams LS, Triantafyllou E, Possamai LA, Bernsmeier C, Mitry RR, O'Brien A, Gilroy D, Goldin R, Heneghan M, Heaton N, Jassem W, Bernal W, Vergani D, Ma Y, Quaglia A, Wendon J, Thursz M.

Hepatology. 2014 Apr;59(4):1564-76. doi: 10.1002/hep.26933. Epub 2014 Feb 28.

PMID:
24282114
20.

When a colonoscopy becomes a duodenoscopy: a palliative treatment of a malignant sigmoidoduodenal fistula.

Huber X, Droeser RA, Bernsmeier C, Kirchhoff P.

BMJ Case Rep. 2013 May 24;2013. pii: bcr2012008241. doi: 10.1136/bcr-2012-008241.

21.

Daptomycin for highly resistant Enterococcus faecium infection.

Rosin C, Bernsmeier C, Entenza JM, Moreillon P, Frei R, Weisser M, Flückiger U.

Swiss Med Wkly. 2012 Jun 26;142:w13603. doi: 10.4414/smw.2012.13603. eCollection 2012.

22.

S-adenosyl-methionine and betaine improve early virological response in chronic hepatitis C patients with previous nonresponse.

Filipowicz M, Bernsmeier C, Terracciano L, Duong FH, Heim MH.

PLoS One. 2010 Nov 8;5(11):e15492. doi: 10.1371/journal.pone.0015492. Erratum in: PLoS One. 2010;5(11). doi: 10.1371/annotation/14d47e6a-400a-429e-a487-6dd375e04632.

23.

Levosimendan as treatment option in severe verapamil intoxication: a case report and review of the literature.

Osthoff M, Bernsmeier C, Marsch SC, Hunziker PR.

Case Rep Med. 2010;2010. pii: 546904. doi: 10.1155/2010/546904. Epub 2010 Aug 11.

24.

Insulin resistance in chronic hepatitis C: mechanisms and clinical relevance.

Bernsmeier C, Heim MH.

Swiss Med Wkly. 2009 Nov 28;139(47-48):678-84. doi: smw-12765. Review.

PMID:
20047129
25.

Virus-induced over-expression of protein phosphatase 2A inhibits insulin signalling in chronic hepatitis C.

Bernsmeier C, Duong FH, Christen V, Pugnale P, Negro F, Terracciano L, Heim MH.

J Hepatol. 2008 Sep;49(3):429-40. doi: 10.1016/j.jhep.2008.04.007. Epub 2008 Apr 30.

PMID:
18486982
26.

Inhibition of alpha interferon signaling by hepatitis B virus.

Christen V, Duong F, Bernsmeier C, Sun D, Nassal M, Heim MH.

J Virol. 2007 Jan;81(1):159-65. Epub 2006 Oct 25.

27.

Peginterferon-alpha-2a (40KD) and ribavirin for 16 or 24 weeks in patients with genotype 2 or 3 chronic hepatitis C.

von Wagner M, Huber M, Berg T, Hinrichsen H, Rasenack J, Heintges T, Bergk A, Bernsmeier C, Häussinger D, Herrmann E, Zeuzem S.

Gastroenterology. 2005 Aug;129(2):522-7.

PMID:
16083709

Supplemental Content

Loading ...
Support Center